Skip to content

Cardinal Health CAH Other Segments — Goodwill, Acquired During Period

Other segment segments

Pharmaceutical and Specialty Solutions
$1.9B+149%
Cost of product sold
$0

Similar metrics at other companies

Medtronic logo
MDTOther Operating Segments — Goodwill as a result of acquisitions
$0
Energy Transfer logo
ETAll Other Segments — Goodwill, Acquired During Period
$0
Thor Industries logo
THOOther — Goodwill acquired
$3.75M
Sysco logo
SYYOther — Goodwill acquired during year
$0
Monster Beverage logo
MNSTAll Other Segments — Goodwill Acquired
$0
National Healthcare logo
NHCAll Other Segments — Goodwill Acquired
$0

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$54.98B+41.0%
Enterprise value$59.96B+38.3%
P/E35.4×+10.3×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%
Debt / equity4.1×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's other segments — goodwill, acquired during period.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's other segments — goodwill, acquired during period?
Cardinal Health (CAH) reported other segments — goodwill, acquired during period of -$1M in Q1 2026.
What does other segments — goodwill, acquired during period mean?
The amount of goodwill recognized during the reporting period specifically attributable to acquisitions integrated into the 'Other' business segment. This metric tracks the growth of intangible assets resulting from inorganic expansion activities outside the core pharmaceutical and medical-surgical businesses. It provides insight into the company's strategy for diversifying its portfolio through targeted acquisitions.